Turnstone Biologics Corp. Common Stock (TSBX) — Financial Flexibility Index
Turnstone Biologics Corp. Common Stock (TSBX) has a Financial Flexibility Index of -0.68x as of June 2025. Free cash flow of $-4.30 Million (operating CF $-4.30 Million minus capex $0.00) represents -1% of total liabilities ($6.34 Million). Also explore TSBX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Turnstone Biologics Corp. Common Stock Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Turnstone Biologics Corp. Common Stock across 4 annual periods. Check TSBX financial resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Turnstone Biologics Corp. Common Stock (2021–2024)
Year-by-year free cash flow to debt coverage for Turnstone Biologics Corp. Common Stock. For the full company profile including market capitalisation, see Turnstone Biologics Corp. Common Stock market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -7.75x | $-67.21 Million | $-67.44 Million | $8.67 Million | ▼ -68.9% |
| 2023 | -4.59x | $-64.90 Million | $-66.15 Million | $14.15 Million | ▼ -1406.6% |
| 2022 | -0.30x | $-65.89 Million | $-71.06 Million | $216.41 Million | ▼ -94.1% |
| 2021 | -0.16x | $-42.22 Million | $-45.63 Million | $269.10 Million | — |